Basepair
Private Company
Total funding raised: $5.6M
Overview
Basepair, founded in 2015 and headquartered in New York, has developed a distinctive cloud bioinformatics platform that addresses critical pain points in genomic data analysis: data movement, cost, and accessibility. Its key differentiator is the ability to provision its SaaS solution directly within a client's existing AWS cloud environment, allowing organizations to maintain full data governance and leverage prior infrastructure investments. The company targets a broad market from academic researchers to diagnostic developers, offering flexible pricing and tools that democratize analysis for both bench scientists and bioinformaticians. Strategic partnerships with AWS, NVIDIA, and global distributors underscore its growth trajectory in the federated genomics analysis space.
Technology Platform
Federated, cloud-native SaaS platform for NGS data analysis that deploys within a customer's own AWS account, featuring a GUI/CLI interface, pre-built & custom workflows, interactive visualization, and white-labeling capabilities.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
Basepair competes in a fragmented market including open-source workflow managers (Nextflow, Snakemake), legacy informatics suites from sequencing giants (Illumina DRAGEN, Thermo Fisher), and other commercial cloud bioinformatics platforms (DNAnexus, Seven Bridges, Partek Flow). Its primary differentiation is the federated deployment model that prioritizes data sovereignty and cost control, setting it apart from vendors who require data upload to their managed clouds.